Clinic Attendance Default among Patients with Chronic Hepatitis B Infection in a Low-Income Setting: A Cause for Concern

Abiodun Christopher Jemilohun, Oluwaseun Gbadebo Adewoye, Dhikrullah Adeyemi Adebayo, Augustin Leke Odanye


Background: Nigeria carries a heavy burden of the disease as about 25 million Nigerians are chronically infected with the disease. It is conventionally believed that default rates are high among CHB patients attending gastroenterology clinics across Nigeria but the actual rates and the reasons for such among the patients have not been quantitatively evaluated. We, therefore, evaluated the clinic attendance default rate and the factors influencing this among chronic hepatitis B patients attending the Gastroenterology Clinic of a Nigerian tertiary healthcare facility.

Material and Methods: The study was a descriptive cross-sectional survey involving chronic hepatitis B patients that attended a Gastroenterology Clinic between July 2011 to December 2016. Case files of patients were retrieved from the medical record department from which their phone numbers and relevant data were obtained. A predesigned questionnaire containing questions relating socio-demographic characteristics, knowledge of chronic hepatitis B, reasons for clinic attendance default and what could be done to make the patient keep clinic appointments was administered to each participant.

Results: A total of 87 subjects aged 18 to 55 years were interviewed. The clinic attendance default rate was 87.4% and 61.8% of the defaulters did so after the first clinic appointment. HBV knowledge [ OR = 9.10 (95% CI 2.33 -35.63), P = 0.002] and the monthly family income [OR = 1.01(95% CI 1.00 -1.02), P =0.008] of the participants were found to be positively associated with clinic attendance.

Conclusion: There was a high rate of clinic attendance default among the population of CHB patients we studied. Inadequate disease knowledge and financial incapability stood as two major factors needing attention in order to solve this problem.


Chronic hepatitis B, Clinic attendance, Default, Low income, Nigeria


Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004;11:97–107.

Hou J, Liu Z, Gu F. Epidemiology and Prevention of Hepatitis B Virus Infection. Int J Med Sci. 2005;2:50–7.

Papatheodoridis G, Buti M, Cornberg M, Janssen H, Mutimer D, Pol S, et al. EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. J Hepatol. 2012;57:167–85.

Lin X, Robinson NJ, Thursz M, Rosenberg DM, Weild A, Pimenta JM, et al. Chronic hepatitis B virus infection in the Asia-Pacific region and Africa: review of disease progression. J Gastroenterol Hepatol. 2005;20:833–43.

The World Factbook [homepage on the internet]. [updated 2017 June 15; cited 2017 June 28]. Available from:

Nwokediuko SC. Chronic hepatitis B: management challenges in resource-poor countries. Hepat Mon. 2011;11:786–93.

Kramvis A, Kew MC. Epidemiology of hepatitis B virus in Africa, its genotypes and clinical associations of genotypes. Hepatol Res. 2007;37(Suppl 1):9–19.

Musa BM, Bussell S, Borodo MM, Samaila AA, Femi OL. Prevalence of hepatitis B virus infection in Nigeria, 2000-2013: a systematic review and meta-analysis. Niger J Clin Pract. 2015;18:163–72.

El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterol. 2012;142:1264–1273.

Papatheodoridis G V., Chan HL-Y, Hansen BE, Janssen HLA, Lampertico P. Risk of hepatocellular carcinoma in chronic hepatitis B: Assessment and modification with current antiviral therapy. J Hepatol. 2015;62:956–67.

Pita I, Horta-Vale AM, Cardoso H, Macedo G. Hepatitis B inactive carriers: An overlooked population? GE Port J Gastroenterol. 2014;21:241–9.

Full Text: PDF HTML


  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.